LENZ Therapeutics, Inc. (LENZ)
(Delayed Data from NSDQ)
$27.25 USD
+1.02 (3.89%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $27.24 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.47 |
EPS Last Quarter | -0.40 |
Last EPS Surprise | 18.37% |
ABR | 1.14 |
Earnings ESP
|
3.23% |
---|---|
Current Year | -3.15 |
Next Year | -2.84 |
EPS (TTM) | -9.24 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 6.95M |
# of Estimates | NA | NA | NA | 5 |
High Estimate | NA | NA | NA | 13.20M |
Low Estimate | NA | NA | NA | 2.30M |
Year ago Sales | 0.00M | NA | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.47 | -0.51 | -3.15 | -2.84 |
# of Estimates | 6 | 5 | 6 | 6 |
Most Recent Consensus | -0.45 | -0.48 | -4.86 | -3.05 |
High Estimate | -0.41 | -0.39 | -1.87 | -2.32 |
Low Estimate | -0.59 | -0.68 | -4.90 | -3.24 |
Year ago EPS | -1.33 | NA | NA | -3.15 |
Year over Year Growth Est. | 64.66% | NA | NA | 9.90% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.47 | -0.51 | -3.15 | -2.84 |
7 Days Ago | -0.47 | -0.51 | -3.15 | -2.84 |
30 Days Ago | -0.47 | -0.52 | -2.81 | -2.80 |
60 Days Ago | -0.47 | -0.52 | -2.81 | -2.80 |
90 Days Ago | -0.39 | -0.34 | -3.06 | -2.82 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.45 | -0.48 | -4.86 | -3.05 |
Zacks Consensus Estimate | -0.47 | -0.51 | -3.15 | -2.84 |
Earnings ESP | 3.23% | 5.51% | -54.20% | -7.39% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.40 | -3.53 | NA | -1.33 | NA |
Estimate | -0.49 | -0.84 | NA | -1.75 | NA |
Difference | 0.09 | -2.69 | NA | 0.42 | -0.73 |
Surprise | 18.37% | -320.24% | NA | 24.00% | -92.62% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more